Literature DB >> 35883030

Shortening door-to-puncture time and improving patient outcome with workflow optimization in patients with acute ischemic stroke associated with large vessel occlusion.

Shuiquan Yang1, Weiping Yao2, James E Siegler3, Mohammad Mofatteh4, Jack Wellington5, Jiale Wu6,7, Wenjun Liang1, Gan Chen1, Zhou Huang8, Rongshen Yang6,7, Juanmei Chen9, Yajie Yang10, Zhaohui Hu11, Yimin Chen12.   

Abstract

OBJECTIVE: We aimed to evaluate door-to-puncture time (DPT) and door-to-recanalization time (DRT) without directing healthcare by neuro-interventionalist support in the emergency department (ED) by workflow optimization and improving patients' outcomes.
METHODS: Records of 98 consecutive ischemic stroke patients who had undergone endovascular therapy (EVT) between 2018 to 2021 were retrospectively reviewed in a single-center study. Patients were divided into three groups: pre-intervention (2018-2019), interim-intervention (2020), and post-intervention (January 1st 2021 to August 16th, 2021). We compared door-to-puncture time, door-to-recanalization time (DRT), puncture-to-recanalization time (PRT), last known normal time to-puncture time (LKNPT), and patient outcomes (measured by 3 months modified Rankin Scale) between three groups using descriptive statistics.
RESULTS: Our findings indicate that process optimization measures could shorten DPT, DRT, PRT, and LKNPT. Median LKNPT was shortened by 70 min from 325 to 255 min(P < 0.05), and DPT was shortened by 119 min from 237 to 118 min. DRT shortened by 132 min from 338 to 206 min, and PRT shortened by 33 min from 92 to 59 min from the pre-intervention to post-intervention groups (all P < 0.05). Only 21.4% of patients had a favorable outcome in the pre-intervention group as compared to 55.6% in the interventional group (P= 0.026).
CONCLUSION: This study demonstrated that multidisciplinary cooperation was associated with shortened DPT, DRT, PRT, and LKNPT despite challenges posed to the healthcare system such as the COVID-19 pandemic. These practice paradigms may be transported to other stroke centers and healthcare providers to improve endovascular time metrics and patient outcomes.
© 2022. The Author(s).

Entities:  

Keywords:  Door-to-puncture time; Door-to-recanalization time; Endovascular therapy; Ischemic stroke; Puncture-to-recanalization time; Workflow optimization

Mesh:

Year:  2022        PMID: 35883030      PMCID: PMC9315077          DOI: 10.1186/s12873-022-00692-8

Source DB:  PubMed          Journal:  BMC Emerg Med        ISSN: 1471-227X


Introduction

Stroke affects one-fifth of the world’s population and is the leading cause of mortality in China [1]. Endovascular thrombectomy has been proven to reduce disability in ischemic stroke patients with large vessel occlusion when performed within 6 h, or in selected patients up to 24 h post-stroke onset [2]. More favorable patient outcomes are observed when shorter delays in pre-hospital care and cumulative time from symptom recognition to treatment [3, 4]. Endovascular treatment has also been associated with a lower risk of complications, including symptomatic intracranial hemorrhage (sICH), achieving discharge independent walking, and lower in-hospital death or hospice discharge when patients are treated soon after ictus [3, 4]. Current guidelines strongly recommend providers effectively shorten intraarterial therapy time for patients with ischemic stroke to improve patient outcomes and explore process improvement initiatives to optimize patient throughput [5]. One study has demonstrated that the direct involvement of neuro-interventionalists in the emergency department (ED) could shorten the door-to-puncture time (DPT) from 167.2 ± 54.3 min to 135.2 ± 50.0 min (P = 0.040) [6]. Another study showed that multidisciplinary cooperation with regular training and debriefing might also shorten the door-to-needle time (DNT) even during the COVID-19 pandemic [7]. Our Foshan Sanshui District People’s hospital is the only comprehensive tertiary hospital and national stroke center that serves more than 0.8 million people, providing intravenous (IV) thrombolysis and endovascular therapy for acute ischemic stroke patients. Due to staffing availability, our neuro-interventionalists do not respond to the ED for stroke codes. With that in mind, we aimed to shorten the DPT and door-to-recanalization time (DRT) without the involvement of neuro-interventionalist support in the ED through nursing and provider education, process optimization, and faster facilitation of transfer of patients between departments.

Methods

Design and setting

This study included the retrospective analysis of prospectively collected data from 98 consecutive ischemic stroke patients who underwent endovascular therapy from 2018 to 2021 in a single-center study in Foshan Sanshui District People’s Hospital in China. We compared time to interventions across three patient groups according to timing of intervention: pre-intervention (2018–2019; n = 14), interim-intervention (2020; n = 39), and post-intervention (January 1st 2021 to August 16th, 2021; n = 45). Inclusion criteria were as follows: age ≥ 18 years old; admitting diagnosis of acute ischemic stroke due to an acute occlusion of the internal carotid artery, M1 or M2 segments of the middle cerebral artery, or basilar artery; stroke onset or last known well within 24 h of thrombectomy. The hospital institutional review board approved the study protocol Informed consent was waived due to the nature of a retrospective observational study.

Data collection

For all patients included in this study, we recorded the following demographics and information: age, sex, past medical history of hypertension, atrial fibrillation (AF), diabetes mellitus (DM), chronic kidney disease (CKD), coronary heart disease (CAD), dyslipidemia, history of stroke, and smoking status. Neurologists measured and recorded the National Institute of Health Stroke Scale (NIHSS), Pre- endovascular therapy (EVT) Alberta Stroke Program Early CT Score (ASPECTS), initial premorbid modified Rankin Scale (mRS), Trial of ORG 10,172 in Acute Stroke Treatment (TOAST) stroke classification, and treatment with IV thrombolysis. DPT, DRT, puncture-to-recanalization time (PRT), and last known normal-to-puncture time (LKNPT) were collected. Three-month mRS scores were evaluated by routine follow-up.

Interventions

Potential improvement points were identified in our hospital by multiple discussions and meetings with medical colleagues, the hospital chief and staff. Table 1 summarizes improvement measures implemented. Each measure was introduced and implemented during the interim-intervention period.
Table 1

A summary of improvement measures implemented with details provided for each measure

MeasuresDetails
Chief of hospital engagementThe chief of the hospital was engaged in the introduction process of the measures to facilitate improving stroke workflow
Pre-notificationA pre-notification system was established via referral hospital doctors to communicate a history of patients from the next of kin and assess thrombectomy treatment benefits and risks for suspected ischemic large vessel occlusion patients
TrainingMultiple training sessions were provided for stroke and emergency nurses to promptly recognize stroke signs and symptoms
PrioritySuspected ischemic stroke patients were prioritized for triage by an emergency doctor
CT was prioritized for suspected ischemic stroke patients
CTA or MRA for suspected ischemic stroke large vessel occlusion patients within 24 h of onset was prioritized
When CTA was performed, CTA images were reconstructed by radiologists in real-time to facilitate rapid imaging interpretation
CT was primarily used for all patients, but MRI/MRA/CTP/MRP was prioritized for suspected ischemic stroke patients
Neurointerventionalist availability for emergency procedures was prioritized for patients with intracranial occlusion
Reduce proceduresImplementation of a modified direct-to-Digital Subtraction Angiography approach, bypassing CTA for selected patients with a clinical suspicion of large vessel occlusion and lack of intracranial hemorrhage on initial CT
More rapid acquisition of consent with support of other providers
Neuro-interventionists team cooperationCooperation of two experienced neuro-interventionists, with one discussing with patients’ family members to acquire consent for thrombectomy, and the other preparing patients for thrombectomy
Green light routeMedical department decision in the best interest of the patient to whether thrombectomy could be performed in critical or emergency situations if a patient family member could be contacted
Surgery was provided without delays for hospital fees payment for all patients
Prepare in advancePreparation of the medications and required devices for thrombectomy in advance by an interventional nurse once the notification is received
FeedbackHolding monthly stroke meetings to analyze the etiology of DPT-delayed cases by hospital chief and the ED staff, neurology, and radiology department staff
RewardRewarding participation of intervention center, ED staff, neurology, and radiology departments financially if DPT was performed less than or equal to 120 min and if patient outcomes were above satisfactory level
Public educationIncreasing the awareness of the public about the signs and symptoms of acute stroke and thrombectomy by using local newspapers, television programs and the Internet platform by Regional Health Bureau and Media Department of the hospital

Abbreviations- CT Computerized tomography, CTA Computed tomography angiography, CTP Computed tomography perfusion, DPT Door-to-puncture time, ED Emergency department, MRA Magnetic resonance angiography, MRP Magnetic resonance perfusion

A summary of improvement measures implemented with details provided for each measure Abbreviations- CT Computerized tomography, CTA Computed tomography angiography, CTP Computed tomography perfusion, DPT Door-to-puncture time, ED Emergency department, MRA Magnetic resonance angiography, MRP Magnetic resonance perfusion

Outcome measurements

The modified Treatment In Cerebral Infarction (mTICI) score was used to assess the recanalization rate [8]. Successful recanalization was defined as TICI 2b to 3. Modified Rankin scale (mRS) scores were determined by phone calls or in-person outpatient appointments and used to assess patient outcomes at 90 days, which was collected by a trained and dedicated stroke nurse navigator following the implementation period, as required for certification of a national stroke center [9]. The favorable outcome was defined as mRS 0–2 at 90 days. Symptomatic intracranial hemorrhage (sICH) was defined by The Heidelberg Bleeding Classification as a new intracranial hemorrhage associated with ≥ 4-point worsening in NIHSS, or ≥ 2-point worsening in a single NIHSS item—neither of which would be attributed to a process other than the hemorrhage [10].

Statistical analyses

The non-parametric Mann–Whitney U test was performed using IBM SPSS version 23 (IBM-Armonk, NY) to analyze non-normally distributed continuous data, reported as medians along with the interquartile range (IQR). Normally distributed data are reported as means with corresponding standard deviations (SD) and compared using the student’s t-test. Results were considered statistically significant if the P-value was less than 0.05. No adjustments were made for multiple hypotheses testing. The results were reported using the STrengthening the Reporting of OBservational Studies in Epidemiology (STROBE) guidelines [11].

Results

There were 98 patients evaluated during the study period who were included in the final analysis. There were no statistically significant differences regarding age, sex, cerebrovascular risk factors, mRS pre-treatment, pre-treatment ASPECTS, and IV thrombolysis of study participants between pre-intervention, interim-intervention, and post-intervention groups (Table 2). Admission NIHSS (IQR) of study participants between pre-intervention, interim-intervention and post-intervention groups were 19.0 (11.0, 21.0), 14.0 (11.0, 18.0), and 17.0 (14.0, 21.0) respectively (P = 0.026). There was a significant distribution in stroke mechanisms between the study periods based on TOAST definition (P = 0.028; Table 2).
Table 2

Clinical and imaging data for different phases of the study. P values are provided for each component

Pre-interventionInterim-interventionPost-interventionP
Number143945
Age, mean ± SD61.5766.8765.290.434
Male, n, %11 (78.6%)30 (76.9%)31 (68.9%)0.643
Hypertension, n, %6 (42.9%)24 (61.5%)30 (66.7%)0.679
AF, n, %6 (42.9%)13 (33.3%)17 (37.8%)0.802
DM, n, %1 (7.1%)6 (15.4%)11 (24.4%)0.284
CAD, n, %4 (28.6%)9 (23.1%)9 (20.0%)0.792
Previous Stroke, n, %1 (7.1%)10 (25.6%)9 (20.0%)0.336
Dyslipidemia, n, %,1 (7.1%)5 (12.8%)9 (20.0%)0.434
CKD, n, %0 (0.0%)3 (7.7%)7 (15.6%)0.193
Smoker, n, %7 (50.0%)12 (30.8%)9 (20.0%)0.088
mRS pre-treatment (IQR)0.0 (0.0,0.0)0.0 (0.0,0.0)0.0 (0.0,0.0)0.597
pre-treatment ASPECTS (IQR)9.0 (8.0,9.0)8.0 (8.0,9.0)8.0 (7.5,9.0)0.184
Admission NIHSS (IQR)19.0 (11.0,21.0)14.0 (11.0,18.0)17.0 (14.0,21.0)0.026
Vessels occlusion
 ICA, n, %2 (14.3%)8 (20.5%)6 (13.3%)0.697
 M1, n, %5 (35.7%)16 (41.0%)22 (48.9%)
 M2, n, %0 (0.0%)1 (2.6%)0 (0.0%)
 Basilar artery, n, %5 (35.7%)8 (20.5%)14 (31.1%)
 Tandem, n, %2 (14.3%)6 (15.4%)3 (6.67%)
TOAST type
 LAA, n, %3 (21.4%)22 (56.4%)19 (42.2%)0.028
 CE, n, %6 (42.9%)15 (38.5%)22 (51.2%)
 SVO, n, %0 (0.0%)1 (2.6%)0 (0.0%)
 SOE, n, %3 (21.4%)0 (0.0%)2 (4.4%)
 SUE, n, %2 (14.3%)1 (2.6%)2 (4.4%)
 IV Thrombolysis, n, %7 (50.0%)18 (46.2%)23 (51.1%)0.942

Abbreviations – AF Atrial fibrillation, DM Diabetes mellitus, CKD Chronic kidney disease, CAD Coronary heart disease, ICA Internal carotid artery, IV Intravenous, LAA Large-artery atherosclerosis, CE Cardioembolism, SOE Stroke of undetermined etiology, SUE Stroke of undetermined etiology, SVO Small vessel occlusion

Clinical and imaging data for different phases of the study. P values are provided for each component Abbreviations – AF Atrial fibrillation, DM Diabetes mellitus, CKD Chronic kidney disease, CAD Coronary heart disease, ICA Internal carotid artery, IV Intravenous, LAA Large-artery atherosclerosis, CE Cardioembolism, SOE Stroke of undetermined etiology, SUE Stroke of undetermined etiology, SVO Small vessel occlusion Post-intervention measures, such as the median LKNPT was shorter post-intervention (255 vs. 325 min, P< 0.05; Table 3, Fig. 1). Similarly, DPT, DRT, and PRT were all significantly (P < 0.05) shorter in the post-intervention period versus pre-intervention period (118 vs. 237 min; 206 vs. 338 min; and PRT 59 vs. 92 min, respectively).
Table 3

Time metrics (min) for different phases of the study. P values are provided for each component. P1: P value for the pre-intervention vs Interim-intervention comparison. P2: P value for the pre-intervention vs post-intervention comparison. P3: P value for the interim-intervention vs post-intervention comparison

Pre-interventionInterim-interventionpost-interventionPP1P2P
LKNPT(IQR) 325.0 (301.0, 503.6)291.0 (220.0, 540.0)255.0 (186.5, 424.0)0. 0480.6860.0600.372
DPT(IQR)237.0 (203.8, 298.0)152.0 (105.0, 203.0)118.0 (98.0, 153.5)0.0000.0010.0000.039
DRT(IQR)338.0 (291.3, 407.3)243.0 (177.0, 322.0)206.0 (143.0, 238.0)0.0000.0140.0000.019
PRT(IQR) 92.0 (57.5, 125.3)81.0 (52.0, 118.0)59.0 (40.5, 91.0)0.0470.1840.0560.049

Abbreviations—LKNPT Last known normal-to-puncture time, DPT Door-to-puncture time, DRT Door-to-recanalization time, PRT puncture-to-recanalization time

Fig. 1

Median LKNPT, DPT, DRT, and PRT (min) from 2018 to 2021. All measurements showed a decreasing trend across the study period

Time metrics (min) for different phases of the study. P values are provided for each component. P1: P value for the pre-intervention vs Interim-intervention comparison. P2: P value for the pre-intervention vs post-intervention comparison. P3: P value for the interim-intervention vs post-intervention comparison Abbreviations—LKNPT Last known normal-to-puncture time, DPT Door-to-puncture time, DRT Door-to-recanalization time, PRT puncture-to-recanalization time Median LKNPT, DPT, DRT, and PRT (min) from 2018 to 2021. All measurements showed a decreasing trend across the study period The target goal of DPT ≤ 120 min is illustrated in Table 4 and Fig. 2. The target goal was statistically significant (P = 0.006) and showed consistent improvement.
Table 4

Target goal of DPT ≤ 120 min for different phases of the study. The P value is provided

Door-to-puncture time (min)Pre-interventionInterim-interventionPost-interventionP value
N = 14N = 39N = 45
DPT ≤ 120 min, n (%)1 (7.1%)13 (33.3%)24 (53.3%)0.006
Fig. 2

The target goal of DPT ≤ 120 min showed consistent improvements over the study period

Target goal of DPT ≤ 120 min for different phases of the study. The P value is provided The target goal of DPT ≤ 120 min showed consistent improvements over the study period The target goal of DPT ≤ 120 min improved from 7.1% in 2018–2019 to 33.3% in 2020, and 53.30% in 2021 in the post-intervention period (P = 0.006). No statistically significant difference was observed concerning the rate of pneumonia, TICI post ≥ 2b, mRS at discharge, inpatient mortality or hospice discharge, and patient mortality at three months. In the post-intervention group, 55.6% had a favorable outcome, and only 21.4% had a favorable outcome measured at 3 months (P = 0.026) in the pre-intervention group (Table 5).
Table 5

Comparison of patient outcomes at different phases of the study. P1: P value for the pre-intervention vs Interim-intervention comparison. P2: P value for the pre-intervention vs post-intervention comparison. P3: P value for the interim-intervention vs post-intervention comparison

Pre-intervention, n = 14Interim-intervention, n = 39Post-intervention, n = 45PP1P2P3
Pneumonia, n, %6 (42.9%)16 (41.0%)15 (33.3%)0.7020.9050.5160.466
TICI post ≥ 2b, n, %11 (78.6%)34 (87.2%)37 (82.2%)0.7090.4400.7590.531
Urinary tract infection, n, %1 (9.1%)0 (0.0%)4 (8.9%)0.1690.0920.8380.056
sICH, n, %,5 (35.7%)6 (15.4%)4 (8.9%)0.0520.1080.0150.359
mRS discharge (IQR)4.0 (4.0,5.0)4.0 (2.0,5.0)3.0 (1.0,5.0)0.5150.9760.5160.486
Inpatient Mortality/hospice discharge, n, %3 (21.4%)9 (23.1%)10 (22.2%)0.9910.8990.0950.926
The favorable outcome at 3 months, n, %3 (21.4%)16 (41.0%)25 (55.6%)0.0670.1900.0260.184
Mortality at 3 months, n, %7 (50.0%)15 (38.5%)13 (28.9%)0.3190.4520.1450.353
Comparison of patient outcomes at different phases of the study. P1: P value for the pre-intervention vs Interim-intervention comparison. P2: P value for the pre-intervention vs post-intervention comparison. P3: P value for the interim-intervention vs post-intervention comparison Ninety day outcomes according to the interval of DPT are summarized in Table 6, indicating a non-significant trend toward better outcomes among patients who achieved a DPT of 120 min or less, when compared to patients with a DPT of > 180 min.
Table 6

Outcome of different DPT (minutes). P1: P value for the pre-intervention vs Interim-intervention comparison. P2: P value for the pre-intervention vs post-intervention comparison. P3: P value for the interim-intervention vs post-intervention comparison

DPT ≤ 120120 < DPT ≤ 180DPT > 180P1P2P3
MRS (0–2), %21 (55.3%)12 (44.4%)11 (33.3%)0.3900.0640.379
MRS (3–6), %17 (44.7%)15 (55.6%)22 (66.7%)0.3900.0640.379

P1: DPT ≤ 120 vs 120 < DPT ≤ 180; P2: DPT ≤ 120 vs DPT > 180; P3: 120 < DPT ≤ 180 vs DPT > 180

Outcome of different DPT (minutes). P1: P value for the pre-intervention vs Interim-intervention comparison. P2: P value for the pre-intervention vs post-intervention comparison. P3: P value for the interim-intervention vs post-intervention comparison P1: DPT ≤ 120 vs 120 < DPT ≤ 180; P2: DPT ≤ 120 vs DPT > 180; P3: 120 < DPT ≤ 180 vs DPT > 180

Discussion

Our findings in this study indicate that process optimization measures can successfully be implemented to shorten DPT, DRT, PRT, and LKNPT according to available hospital resources. We observed significant improvements in both arrivals to arterial puncture as well as the PRT during the study period. An increase in achieving a 90-day favorable outcome (mRS score of 0 to 2) was also observed, with favorable outcomes non-significantly more common among patients with shorter DPT, as has been shown in prior studies [3, 4]. The most recent American Stroke Association (ASA) guidelines recommends a goal for door-to-endovascular treatment time being restricted to within 120 min of stroke-onset [12]. Following the ASA recommendations, our center successfully improved the deadline of DPT ≤ 120 min from 7.1% in 2018–2019 to 33.3% in 2020 and 53.30% in the 2021 post-intervention period (P = 0.006). With every minute counting to manage such cases, a 90-min DPT for receiving endovascular treatment is considered for optimal management [13]. A recent study also demonstrated there were no significant differences in long-term thrombectomy outcomes among proximal anterior circulation patients who were selected based on non-contrast CT compared as compared to those selected with CTP or MRI in the extended window of 6 to 24 h [14]. Therefore, when possible, the patients may be selected without advanced or additional imaging beyond the CT in order to shorter DPT. Delays in stroke care and reperfusion treatment were a global challenge during the COVID-19 pandemic, corresponding to a global decline in the volume of stroke hospitalizations during the COVID-19 period [15-18]. The Society of Vascular and Interventional Neurology (SVIN) provided a formal guidance statement for recalibrating stroke workflow to protect frontline healthcare workers, their families and colleagues, with individualization of stroke treatment according to patient needs during the COVID-19 pandemic [19]. Strategies to optimize DPT, DRT, PRT, and LKNPT are critical to improve patient outcomes. Once acute stroke patients arrive at the hospital, resources must be allocated to rapidly identify patients with suspected ischemic stroke and intracranial occlusion, and mobilize personnel in order to treat using endovascular interventions. These processes necessitate the involvement of pre-hospital transfer services alongside ED personnel, neurologists, nurses, radiologists, interventionalists, and the hospital administration department. Only by involving each of these stakeholders can the most effective treatment be provided in the timeliest manner. Our study has some limitations. The study is a retrospective study in a single hospital with a small data sample size. Prospective multicenter studies and larger sample data sizes are required to analyze shortened DRT and patient outcomes. Despite these limitations, we believe accomplishments at our center can provide a framework for other stroke centers to improve their patient outcomes.

Conclusions

This study demonstrated that multidisciplinary cooperation could shorten the time to endovascular treatment, with the potential to improve long-term patient outcomes. We call on stroke centers and healthcare providers to internally review their local paradigms to evaluate where improvements can be made to safely expedite care.
  19 in total

1.  Modified Thrombolysis in Cerebral Infarction 2C/Thrombolysis in Cerebral Infarction 3 Reperfusion Should Be the Aim of Mechanical Thrombectomy: Insights From the ASTER Trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization).

Authors:  Cyril Dargazanli; Robert Fahed; Raphael Blanc; Benjamin Gory; Julien Labreuche; Alain Duhamel; Gaultier Marnat; Suzana Saleme; Vincent Costalat; Serge Bracard; Hubert Desal; Mikael Mazighi; Arturo Consoli; Michel Piotin; Bertrand Lapergue
Journal:  Stroke       Date:  2018-04-06       Impact factor: 7.914

Review 2.  Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.

Authors:  Jamie L Banks; Charles A Marotta
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

3.  Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Dana Leifer; Dawn M Bravata; J J Buddy Connors; Judith A Hinchey; Edward C Jauch; S Claiborne Johnston; Richard Latchaw; William Likosky; Christopher Ogilvy; Adnan I Qureshi; Debbie Summers; Gene Y Sung; Linda S Williams; Richard Zorowitz
Journal:  Stroke       Date:  2011-01-13       Impact factor: 7.914

4.  Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.

Authors:  Reza Jahan; Jeffrey L Saver; Lee H Schwamm; Gregg C Fonarow; Li Liang; Roland A Matsouaka; Ying Xian; DaJuanicia N Holmes; Eric D Peterson; Dileep Yavagal; Eric E Smith
Journal:  JAMA       Date:  2019-07-16       Impact factor: 56.272

5.  Improving Door-To-Puncture Time in Mechanical Thrombectomy with Direct Care from a Neurointerventionalist in the Emergency Department.

Authors:  Seung Hwan Kim; Taek Min Nam; Ji Hwan Jang; Young Zoon Kim; Kyu Hong Kim; Do-Hyung Kim; Hyungon Lee; Sung-Chul Jin; Chul Hee Lee
Journal:  World Neurosurg       Date:  2021-06-16       Impact factor: 2.104

Review 6.  Stroke in China: advances and challenges in epidemiology, prevention, and management.

Authors:  Simiao Wu; Bo Wu; Ming Liu; Zhengming Chen; Wenzhi Wang; Craig S Anderson; Peter Sandercock; Yongjun Wang; Yining Huang; Liying Cui; Chuanqiang Pu; Jianping Jia; Tong Zhang; Xinfeng Liu; Suming Zhang; Peng Xie; Dongsheng Fan; Xunming Ji; Ka-Sing Lawrence Wong; Longde Wang
Journal:  Lancet Neurol       Date:  2019-04       Impact factor: 44.182

7.  Global Impact of COVID-19 on Stroke Care and IV Thrombolysis.

Authors:  Raul G Nogueira; Muhammad M Qureshi; Mohamad Abdalkader; Sheila Ouriques Martins; Hiroshi Yamagami; Zhongming Qiu; Ossama Yassin Mansour; Anvitha Sathya; Anna Czlonkowska; Georgios Tsivgoulis; Diana Aguiar de Sousa; Jelle Demeestere; Robert Mikulik; Peter Vanacker; James E Siegler; Janika Kõrv; Jose Biller; Conrad W Liang; Navdeep S Sangha; Alicia M Zha; Alexandra L Czap; Christine Anne Holmstedt; Tanya N Turan; George Ntaios; Konark Malhotra; Ashis Tayal; Aaron Loochtan; Annamarei Ranta; Eva A Mistry; Anne W Alexandrov; David Y Huang; Shadi Yaghi; Eytan Raz; Sunil A Sheth; Mahmoud H Mohammaden; Michael Frankel; Eric Guemekane Bila Lamou; Hany M Aref; Ahmed Elbassiouny; Farouk Hassan; Tarek Menecie; Wessam Mustafa; Hossam M Shokri; Tamer Roushdy; Fred S Sarfo; Tolulope Oyetunde Alabi; Babawale Arabambi; Ernest O Nwazor; Taofiki Ajao Sunmonu; Kolawole Wahab; Joseph Yaria; Haytham Hussein Mohammed; Philip B Adebayo; Anis D Riahi; Samia Ben Sassi; Lenon Gwaunza; Gift Wilson Ngwende; David Sahakyan; Aminur Rahman; Zhibing Ai; Fanghui Bai; Zhenhui Duan; Yonggang Hao; Wenguo Huang; Guangwen Li; Wei Li; Ganzhe Liu; Jun Luo; Xianjin Shang; Yi Sui; Ling Tian; Hongbin Wen; Bo Wu; Yuying Yan; Zhengzhou Yuan; Hao Zhang; Jun Zhang; Wenlong Zhao; Wenjie Zi; Thomas W Leung; Chandril Chugh; Vikram Huded; Bindu Menon; Jeyaraj Durai Pandian; P N Sylaja; Fritz Sumantri Usman; Mehdi Farhoudi; Elyar Sadeghi Hokmabadi; Anat Horev; Anna Reznik; Rotem Sivan Hoffmann; Nobuyuki Ohara; Nobuyuki Sakai; Daisuke Watanabe; Ryoo Yamamoto; Ryosuke Doijiri; Naoki Tokuda; Takehiro Yamada; Tadashi Terasaki; Yukako Yazawa; Takeshi Uwatoko; Tomohisa Dembo; Hisao Shimizu; Yuri Sugiura; Fumio Miyashita; Hiroki Fukuda; Kosuke Miyake; Junsuke Shimbo; Yusuke Sugimura; Yoshiki Yagita; Yohei Takenobu; Yuji Matsumaru; Satoshi Yamada; Ryuhei Kono; Takuya Kanamaru; Hidekazu Yamazaki; Manabu Sakaguchi; Kenichi Todo; Nobuaki Yamamoto; Kazutaka Sonoda; Tomoko Yoshida; Hiroyuki Hashimoto; Ichiro Nakahara; Aida Kondybayeva; Kamila Faizullina; Saltanat Kamenova; Murat Zhanuzakov; Jang-Hyun Baek; Yangha Hwang; Jin Soo Lee; Si Baek Lee; Jusun Moon; Hyungjong Park; Jung Hwa Seo; Kwon-Duk Seo; Sung Il Sohn; Chang Jun Young; Rechdi Ahdab; Wan Asyraf Wan Zaidi; Zariah Abdul Aziz; Hamidon Bin Basri; Law Wan Chung; Aznita Binti Ibrahim; Khairul Azmi Ibrahim; Irene Looi; Wee Yong Tan; Nafisah Wan Yahya; Stanislav Groppa; Pavel Leahu; Amal M Al Hashmi; Yahia Zakaria Imam; Naveed Akhtar; Maria Carissa Pineda-Franks; Christian Oliver Co; Dmitriy Kandyba; Adel Alhazzani; Hosam Al-Jehani; Carol Huilian Tham; Marlie Jane Mamauag; Narayanaswamy Venketasubramanian; Chih-Hao Chen; Sung-Chun Tang; Anchalee Churojana; Esref Akil; Özlem Aykaç; Atilla Ozcan Ozdemir; Semih Giray; Syed Irteza Hussain; Seby John; Huynh Le Vu; Anh Duc Tran; Huy Hoang Nguyen; Thong Nhu Pham; Thang Huy Nguyen; Trung Quoc Nguyen; Thomas Gattringer; Christian Enzinger; Monika Killer-Oberpfalzer; Flavio Bellante; Sofie De Blauwe; Geert Vanhooren; Sylvie De Raedt; Anne Dusart; Robin Lemmens; Noemie Ligot; Matthieu Pierre Rutgers; Laetitia Yperzeele; Filip Alexiev; Teodora Sakelarova; Marina Roje Bedeković; Hrvoje Budincevic; Igor Cindric; Zlatko Hucika; David Ozretic; Majda Seferovic Saric; František Pfeifer; Igor Karpowic; David Cernik; Martin Sramek; Miroslav Skoda; Helena Hlavacova; Lukas Klecka; Martin Koutny; Daniel Vaclavik; Ondrej Skoda; Jan Fiksa; Katerina Hanelova; Miroslava Nevsimalova; Robert Rezek; Petr Prochazka; Gabriela Krejstova; Jiri Neumann; Marta Vachova; Henryk Brzezanski; David Hlinovsky; Dusan Tenora; Rene Jura; Lubomír Jurák; Jan Novak; Ales Novak; Zdenek Topinka; Petr Fibrich; Helena Sobolova; Ondrej Volny; Hanne Krarup Christensen; Nicolas Drenck; Helle Klingenberg Iversen; Claus Z Simonsen; Thomas Clement Truelsen; Troels Wienecke; Riina Vibo; Katrin Gross-Paju; Toomas Toomsoo; Katrin Antsov; Francois Caparros; Charlotte Cordonnier; Maria Dan; Jean-Marc Faucheux; Laura Mechtouff; Omer Eker; Emilie Lesaine; Basile Ondze; Roxane Peres; Fernando Pico; Michel Piotin; Raoul Pop; Francois Rouanet; Tatuli Gubeladze; Mirza Khinikadze; Nino Lobjanidze; Alexander Tsiskaridze; Simon Nagel; Peter Arthur Ringleb; Michael Rosenkranz; Holger Schmidt; Annahita Sedghi; Timo Siepmann; Kristina Szabo; Götz Thomalla; Lina Palaiodimou; Dimitrios Sagris; Odysseas Kargiotis; Peter Klivenyi; Laszlo Szapary; Gabor Tarkanyi; Alessandro Adami; Fabio Bandini; Paolo Calabresi; Giovanni Frisullo; Leonardo Renieri; Davide Sangalli; Anne Pirson; Maarten Uyttenboogaart; Ido van den Wijngaard; Espen Saxhaug Kristoffersen; Waldemar Brola; Małgorzata Fudala; Ewa Horoch-Lyszczarek; Michal Karlinski; Radoslaw Kazmierski; Pawel Kram; Marcin Rogoziewicz; Rafal Kaczorowski; Piotr Luchowski; Halina Sienkiewicz-Jarosz; Piotr Sobolewski; Waldemar Fryze; Anna Wisniewska; Malgorzata Wiszniewska; Patricia Ferreira; Paulo Ferreira; Luisa Fonseca; João Pedro Marto; Teresa Pinho E Melo; Ana Paiva Nunes; Miguel Rodrigues; Vítor Tedim Cruz; Cristian Falup-Pecurariu; Georgi Krastev; Miroslav Mako; María Alonso de Leciñana; Juan F Arenillas; Oscar Ayo-Martin; Antonio Cruz Culebras; Exuperio Diez Tejedor; Joan Montaner; Soledad Pérez-Sánchez; Miguel Angel Tola Arribas; Alejandro Rodriguez Vasquez; Michael Mayza; Gianmarco Bernava; Alex Brehm; Paolo Machi; Urs Fischer; Jan Gralla; Patrik L Michel; Marios-Nikos Psychogios; Davide Strambo; Soma Banerjee; Kailash Krishnan; Joseph Kwan; Asif Butt; Luciana Catanese; Andrew M Demchuk; Thalia Field; Jennifer Haynes; Michael D Hill; Houman Khosravani; Ariane Mackey; Aleksandra Pikula; Gustavo Saposnik; Courtney Anne Scott; Ashkan Shoamanesh; Ashfaq Shuaib; Samuel Yip; Miguel A Barboza; Jose Domingo Barrientos; Ligia Ibeth Portillo Rivera; Fernando Gongora-Rivera; Nelson Novarro-Escudero; Anmylene Blanco; Michael Abraham; Diana Alsbrook; Dorothea Altschul; Anthony J Alvarado-Ortiz; Ivo Bach; Aamir Badruddin; Nobl Barazangi; Charmaine Brereton; Alicia Castonguay; Seemant Chaturvedi; Saqib A Chaudry; Hana Choe; Jae H Choi; Sushrut Dharmadhikari; Kinjal Desai; Thomas G Devlin; Vinodh T Doss; Randall Edgell; Mark Etherton; Mudassir Farooqui; Don Frei; Dheeraj Gandhi; Mikayel Grigoryan; Rishi Gupta; Ameer E Hassan; Johanna Helenius; Artem Kaliaev; Ritesh Kaushal; Priyank Khandelwal; Ayaz M Khawaja; Naim N Khoury; Benny S Kim; Dawn O Kleindorfer; Feliks Koyfman; Vivien H Lee; Lester Y Leung; Guillermo Linares; Italo Linfante; Helmi L Lutsep; Lisa Macdougall; Shailesh Male; Amer M Malik; Hesham Masoud; Molly McDermott; Brijesh P Mehta; Jiangyong Min; Manoj Mittal; Jane G Morris; Sumeet S Multani; Fadi Nahab; Krishna Nalleballe; Claude B Nguyen; Roberta Novakovic-White; Santiago Ortega-Gutierrez; Rahul H Rahangdale; Pankajavalli Ramakrishnan; Jose Rafael Romero; Natalia Rost; Aaron Rothstein; Sean Ruland; Ruchir Shah; Malveeka Sharma; Brian Silver; Marc Simmons; Abhishek Singh; Amy K Starosciak; Sheryl L Strasser; Viktor Szeder; Mohamed Teleb; Jenny P Tsai; Barbara Voetsch; Oscar Balaguera; Virginia A Pujol Lereis; Adriana Luraschi; Marcele Schettini Almeida; Fabricio Buchdid Cardoso; Adriana Conforto; Leonardo De Deus Silva; Luidia Varrone Giacomini; Fabricio Oliveira Lima; Alexandre L Longo; Pedro S C Magalhães; Rodrigo Targa Martins; Francisco Mont'alverne; Daissy Liliana Mora Cuervo; Leticia Costa Rebello; Lenise Valler; Viviane Flumignan Zetola; Pablo M Lavados; Victor Navia; Verónica V Olavarría; Juan Manuel Almeida Toro; Pablo Felipe Ricardo Amaya; Hernan Bayona; Angel Corredor; Carlos Eduardo Rivera Ordonez; Diana Katherine Mantilla Barbosa; Osvaldo Lara; Mauricio R Patiño; Luis Fernando Diaz Escobar; Donoband Edson Dejesus Melgarejo Fariña; Analia Cardozo Villamayor; Adolfo Javier Zelaya Zarza; Danny Moises Barrientos Iman; Liliana Rodriguez Kadota; Bruce Campbell; Graeme J Hankey; Casey Hair; Timothy Kleinig; Alice Ma; Rodrigo Tomazini Martins; Ramesh Sahathevan; Vincent Thijs; Daniel Salazar; Teddy Yuan-Hao Wu; Diogo C Haussen; David Liebeskind; Dileep R Yavagal; Tudor G Jovin; Osama O Zaidat; Thanh N Nguyen
Journal:  Neurology       Date:  2021-03-25       Impact factor: 11.800

8.  Shortening Door-to-Needle Time by Multidisciplinary Collaboration and Workflow Optimization During the COVID-19 Pandemic.

Authors:  Yimin Chen; Thanh N Nguyen; Jack Wellington; Mohammad Mofatteh; Weiping Yao; Zhaohui Hu; Qiuping Kuang; Weijuan Wu; Xuejun Wang; Yu Sun; Kexun Ouyang; Junmiao Xu; Weiquan Huang; Shuiquan Yang
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-10-20       Impact factor: 2.136

9.  The impact of COVID-19 on acute ischemic stroke admissions: Analysis from a community-based tertiary care center.

Authors:  Jing Wang; Saqib A Chaudhry; Pouya Tahsili-Fahadan; Laith R Altaweel; Sairah Bashir; Zelalem Bahiru; Yun Fang; Adnan I Qureshi
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-09-25       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.